Form 144 ABBOTT LABORATORIES For: 2 March
#Form 144 #Abbott Laboratories #ABT #Investing.com #stock decline #U.S.-Iran #gold prices #market volatility
📌 Key Takeaways
- Form 144 filing published for Abbott Laboratories on March 2, 2026
- Abbott Laboratories stock (ABT) declined 1.94%
- Filings published by Investing.com at 8:01 PM
- Market context included U.S.-Iran escalation affecting gold prices and currencies
- Mixed stock performance amid geopolitical tensions
📖 Full Retelling
Investing.com published Form 144 filings for Abbott Laboratories on March 2, 2026, showing the company's stock (ABT) declined 1.94%. This regulatory filing occurred amid market volatility following U.S.-Iran geopolitical tensions, which drove gold prices higher and created mixed stock market performance.
🏷️ Themes
Corporate filings, Market volatility, Geopolitical impact on markets, Pharmaceutical industry, Regulatory compliance
Entity Intersection Graph
No entity connections available yet for this article.
Original Source
try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Gold prices climb amid boost to safe haven demand after U.S.-Iran escalation Dollar surges to over five-week high on U.S.-Iran escalation; euro, sterling slip Stocks end mixed in a solid rebound from initial slide on U.S.-Iran conflict Gold price surge after Iran attack could fade, Pepperstone says FLASH SALE (South Africa Philippines Nigeria) FLASH SALE Form 144 ABBOTT LABORATORIES For: 2 March By Investing.com Filings Published 03/02/2026, 08:01 PM Form 144 ABBOTT LABORATORIES For: 2 March 0 ABT -1.94%
Read full article at source